John Griffin's hedge fund firm Blue Ridge Capital filed a 13G with the SEC and just disclosed a 5.98% ownership stake in Endo Health Solutions (ENDP) with 6,635,000 shares.
This is a brand new position for the hedge fund as they did not report a stake at the end of 2012 in the last portfolio disclosures. The filing was required due to portfolio activity on April 30th.blue rid
Per Google Finance, Endo Health is "a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel."
Friday, May 10, 2013
Blue Ridge Capital Starts Endo Health Solutions (ENDP) Position
blog comments powered by Disqus
